- Director of Cardiovascular and Genetic Epidemiology
- PhD, Genetic Epidemiology
- MStat, Biostatistics
- MPH, Epidemiology
- Fellow of the American Heart Association
- Fellow of the American College of Cardiology
Research and Professional Experience
Dr. Horne is a Professor of Research at Intermountain and has been with Intermountain since 1996. He holds an academic appointment as an Adjunct Clinical Associate Professor in the Division of Cardiovascular Medicine (Department of Medicine) at Stanford University and is a member of the Cardiovascular Institute in the Stanford University School of Medicine (Stanford, CA). His doctoral training (PhD) in genetic epidemiology was completed at the University of Utah and he holds masters degrees in public health and in biostatistics. Dr. Horne is a fellow of the American Heart Association and a fellow of the American College of Cardiology. Dr. Horne’s research focuses on population health and precision medicine, including evaluating the genetic epidemiology of heart diseases, developing and implementing clinical decision tools for personalizing medical care, discovering the human health effects of intermittent fasting, and studying the influences of air pollution on major adverse health events.
- Fasting and Cardiovascular Disease:
Dr. Horne is actively pursuing studies of the relationship between water-only fasting and cardiovascular disease. His projects have found that short-term abstention from caloric intake that is practiced repeatedly over the lifespan may play a role in reducing risk of diabetes and coronary disease.
- Risk Scoring for Adverse Health Outcomes:
Dr. Horne is leading a project to predict adverse health outcomes using common laboratory tests (complete blood count and basic metabolic profile) that are inexpensive, widely available, and easily combined into a risk score outside of the clinical environment for use by physicians.
- Genetic Associations with Myocardial Infarction:
Dr. Horne is collaborating with investigators at various universities, including the University of Utah, the University of Pennsylvania, and the Broad Institute of MIT and Harvard Universities to study genetic associations with myocardial infarction.